## **Core Concept**
The management of raised intracranial pressure (ICP) involves careful consideration of medications that can either increase or decrease ICP. Certain drugs can worsen elevated ICP, making it crucial to select medications that do not adversely affect intracranial dynamics.

## **Why the Correct Answer is Right**
Ketamine can increase cerebral blood flow and cerebral metabolic rate, which in turn can increase ICP. This effect is thought to be due to its action on **NMDA receptors**, leading to cerebral vasodilation. Although the effect of ketamine on ICP has been debated and may be context-dependent, its potential to increase ICP makes it a concern in patients with elevated ICP.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Propofol is often used in neurocritical care for sedation because it can decrease cerebral metabolic rate and has a favorable effect on ICP, generally reducing it or having a neutral effect.
* **Option B:** Midazolam, a benzodiazepine, can decrease ICP and is sometimes used for sedation in patients with elevated ICP, though its effects can be variable.
* **Option D:** Fentanyl, an opioid, generally has a neutral or slightly beneficial effect on ICP, though it can cause respiratory depression.

## **Clinical Pearl / High-Yield Fact**
A key clinical consideration in neuroanesthesia and critical care is the choice of anesthetic agents that do not adversely affect ICP. **Mannitol** is a commonly used osmotic diuretic to reduce ICP, but its use requires careful monitoring of serum osmolarity. Remember, in the context of raised ICP, the safety profile of anesthetics and sedatives regarding their effect on cerebral dynamics is crucial.

## **Correct Answer:** . Ketamine